Cargando…

Cardiovascular and mortality events in type 2 diabetes cardiovascular outcomes trials: a systematic review with trend analysis

AIMS: To investigate cardiovascular disease and mortality trends in control arm participants of diabetes cardiovascular outcome trials (CVOTs). METHODS: We electronically searched CVOTs published before October 2017. Data on all-cause mortality, cardiovascular mortality and events, and baseline char...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vetrone, Lorenzo M., Zaccardi, Francesco, Webb, David R., Seidu, Sam, Gholap, Nitin N., Pitocco, Dario, Davies, Melanie J., Khunti, Kamlesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Milan 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394717/ https://www.ncbi.nlm.nih.gov/pubmed/30456728 http://dx.doi.org/10.1007/s00592-018-1253-5

Ejemplares similares

Cardiovascular events and mortality in people with and without type 2 diabetes: An observational study in a contemporary multi‐ethnic population
por: Coles, Briana, et al.
Publicado: (2020)

Nonlinear association of BMI with all-cause and cardiovascular mortality in type 2 diabetes mellitus: a systematic review and meta-analysis of 414,587 participants in prospective studies
por: Zaccardi, Francesco, et al.
Publicado: (2016)

Use of Metformin and Cardiovascular Effects of New Classes of Glucose-Lowering Agents: A Meta-analysis of Cardiovascular Outcome Trials in Type 2 Diabetes
por: Zaccardi, Francesco, et al.
Publicado: (2021)

Inequalities in cancer mortality trends in people with type 2 diabetes: 20 year population-based study in England
por: Ling, Suping, et al.
Publicado: (2023)

Relationship of cardiometabolic parameters in non-smokers, current smokers, and quitters in diabetes: a systematic review and meta-analysis
por: Kar, Debasish, et al.
Publicado: (2016)

Obesity, walking pace and risk of severe COVID-19 and mortality: analysis of UK Biobank
por: Yates, Thomas, et al.
Publicado: (2021)

Is admission blood glucose concentration a more powerful predictor of mortality after myocardial infarction than diabetes diagnosis? A retrospective cohort study
por: Gholap, Nitin Narayan, et al.
Publicado: (2012)

Global burden of hypoglycaemia-related mortality in 109 countries, from 2000 to 2014: an analysis of death certificates
por: Zaccardi, Francesco, et al.
Publicado: (2018)

Severe hypoglycaemia and absolute risk of cause-specific mortality in individuals with type 2 diabetes: a UK primary care observational study
por: Zaccardi, Francesco, et al.
Publicado: (2020)

The Cardiovascular Relevance of Celiac Disease
por: Pitocco, Dario, et al.
Publicado: (2012)

Outcome trends in people with heart failure, type 2 diabetes mellitus and chronic kidney disease in the UK over twenty years
por: Lawson, Claire A, et al.
Publicado: (2021)

Consultation rates in people with type 2 diabetes with and without vascular complications: a retrospective analysis of 141,328 adults in England
por: Abner, Sophia, et al.
Publicado: (2022)

Prevalence of co‐morbidities and their association with mortality in patients with COVID‐19: A systematic review and meta‐analysis
por: Singh, Awadhesh K., et al.
Publicado: (2020)

Where Does Metformin Stand in Modern Day Management of Type 2 Diabetes?
por: Ahmad, Ehtasham, et al.
Publicado: (2020)

Trends in Cause-Specific Outcomes Among Individuals With Type 2 Diabetes and Heart Failure in the United Kingdom, 1998-2017
por: Lawson, Claire A., et al.
Publicado: (2019)

Association of walking pace and handgrip strength with all-cause, cardiovascular, and cancer mortality: a UK Biobank observational study
por: Yates, Thomas, et al.
Publicado: (2017)

Non‐inferiority and clinical superiority of glucagon‐like peptide‐1 receptor agonists and sodium‐glucose co‐transporter‐2 inhibitors: Systematic analysis of cardiorenal outcome trials in type 2 diabetes
por: Zaccardi, Francesco, et al.
Publicado: (2022)

A Review of Exenatide: Optimizing Glycemic Control and Associated Cardiovascular Risk Factors in Type 2 Diabetes
por: Htike, Zin Z., et al.
Publicado: (2012)

Risk of Diabetes Following COVID-19: Translating Evidence Into Clinical and Public Health Actions
por: Zaccardi, Francesco, et al.
Publicado: (2022)

Associations between frailty trajectories and cardiovascular, renal, and mortality outcomes in chronic kidney disease
por: Wilkinson, Thomas J., et al.
Publicado: (2022)

The impact of obesity on severe disease and mortality in people with SARS‐CoV‐2: A systematic review and meta‐analysis
por: Seidu, Samuel, et al.
Publicado: (2020)

Long terms trends of multimorbidity and association with physical activity in older English population
por: Dhalwani, Nafeesa N., et al.
Publicado: (2016)

Impact of COVID-19 on routine care for chronic diseases: A global survey of views from healthcare professionals
por: Chudasama, Yogini V., et al.
Publicado: (2020)

Prediction of type 2 diabetes risk in people with non-diabetic hyperglycaemia: model derivation and validation using UK primary care data
por: Coles, Briana, et al.
Publicado: (2020)

The Effectiveness of Screening for Diabetes and Cardiovascular Disease Risk Factors in a Community Pharmacy Setting
por: Willis, Andrew, et al.
Publicado: (2014)

Age at diagnosis of type 2 diabetes and cardiovascular risk factor profile: A pooled analysis
por: Barker, Mary M, et al.
Publicado: (2022)

Joint Prevalence of Diabetes, Impaired Glucose Regulation, Cardiovascular Disease Risk and Chronic Kidney Disease in South Asians and White Europeans
por: Khunti, Kamlesh, et al.
Publicado: (2013)

Obesity and risk of COVID-19: analysis of UK biobank
por: Yates, Thomas, et al.
Publicado: (2020)

Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes
por: Paul, Sanjoy K, et al.
Publicado: (2015)

Efficacy and safety of sodium-glucose cotransporter 2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) in patients with type 2 diabetes: a systematic review and network meta-analysis study protocol
por: Hussein, Humaira, et al.
Publicado: (2018)

Adults with early-onset type 2 diabetes (aged 18–39 years) are severely underrepresented in diabetes clinical research trials
por: Sargeant, Jack A., et al.
Publicado: (2020)

Predicting hospital stay, mortality and readmission in people admitted for hypoglycaemia: prognostic models derivation and validation
por: Zaccardi, Francesco, et al.
Publicado: (2017)

Adaptive Immunity, Inflammation, and Cardiovascular Complications in Type 1 and Type 2 Diabetes Mellitus
por: Pedicino, Daniela, et al.
Publicado: (2013)

Serum Potassium and Glucose Regulation in the ADDITION-Leicester Screening Study
por: Carter, Patrice, et al.
Publicado: (2015)

Evaluation of quality of diabetic foot examination on YouTube
por: Almaqhawi, Abdullah, et al.
Publicado: (2022)

Kidney Function and Long-Term Risk of End-Stage Kidney Disease and Mortality in a Multiethnic Population
por: Ling, Suping, et al.
Publicado: (2023)

Therapeutic inertia in type 2 diabetes: prevalence, causes, consequences and methods to overcome inertia
por: Khunti, Sachin, et al.
Publicado: (2019)

Impact of the COVID‐19 Pandemic on Diabetes‐Related Cardiovascular Mortality in the United States
por: Bashar, Hussein, et al.
Publicado: (2023)

COVID-19 vaccine uptake and hesitancy opinions from frontline health care and social care workers: Survey data from 37 countries
por: Chudasama, Radika V., et al.
Publicado: (2022)

COVID-19, ethnicity and cardiometabolic disease self-management in UK primary care
por: Highton, Patrick J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_454dv5haplkk2o7kha3a9d2qm0